Pharma
At our conference, experts in drug delivery alongside device development engineers will offer diverse perspectives on ensuring the compatibility and operational efficiency of drug products and delivery devices, including harmonising design controls with quality by design principles, determining device specifications during early development stages, assessing material compatibility and safety, navigating regulatory pathways and quality management systems, defining essential performance criteria, conducting design verification and validation, managing risk factors, ensuring device compliance and meeting essential performance standards, and facilitating compatibility and clinical assessments. #VLDDCP
Read moreExperts in drug delivery and device development will discuss ensuring the compatibility and efficiency of drug products and delivery devices. Topics include harmonising design controls with quality by design, determining device specifications early on, assessing material safety, navigating regulatory pathways, defining performance criteria, conducting verification and validation, managing risks, ensuring compliance, and facilitating clinical assessments. This collaboration addresses the importance of harmony between drug products and delivery mechanisms, especially during initial development phases, overcoming hurdles in formulation, dosage, and regulatory complexities for the successful advancement of combined drug-device products.
Executives, Directors, Heads, Leaders, Managers, Specialists, Engineers Professionals in Pharmaceuticals, Principal Scientists, Principal Toxicologists, QC Laboratories, Manufacturers of Drug Substances (APIs), Contract Laboratories, Oral Solid Dosage Form, Clinical Research Org., Contract Research Org., Contract Manufacturing Org., Biopharma Companies, Biotechnology Prod., and Fellows specialising in:
To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.
Bjarne Sørensen is a director of front-end innovation at Phillips-Medisize, based in the company’s development centre in Denmark. With more than 35 years of experience within product, strategy, and business development, Bjarne has a very visible track record within different business areas. At Phillips-Medisize, he participates in customer projects, typically involving electronic injectors and connected health systems. He is also deeply involved in new electronic platform programs, especially on conceptual, technical, and sustainability aspects.
Paul Johnson Consulting Limited
Paul Johnson is an independent consultant to the pharmaceutical industry who has specialised in the CMC aspects of NCE and generic inhaled product development since 2018 serving clients in large/small pharma companies, pharmaceutical component suppliers, and pharmaceutical service providers.
Paul gained 20 years of experience leading teams and projects involved for the development of inhaled products at Glaxo Smith Kline in a range of delivery systems, including dry powder inhalers, pressurised metered dose inhalers, and nebulisers. He is most proud to have led the CMC teams from early development, through clinical stages, registration, launch and lifecycle management for Relvar/Breo Ellipta, and provided leadership for the CMC aspects for the entire GSK inhaled franchise.
Beyond Conception GmbH
Paul Johnson Consulting Limited
Beyond Conception GmbH
Request the 6th Drug-Device Combination Products Conference brochure and find out the latest topics and ideas that will be shared.
Please fill in your e-mail address below and we will process your request in a moment.
Apr 20, 2018
2nd Annual Drug/Device Combination Products Summit
May 18, 2017
2nd Annual Antibody Drug Conjugates (ADC) Summit
Pharma
Pharma
Pharma
Pharma
Pharma
Pharma
